CCR2-64I polymorphism and CCR5Δ32 deletion in patients with Alzheimer's disease

Journal of the Neurological Sciences

Volumn 225, Issue 1-2, 2004, Pages 79-83

  Galimberti, Daniela ^a   Fenoglio, Chiara ^a   Lovati, Carlo ^b   Gatti, Alberto ^a   Guidi, Ilaria ^a   Venturelli, Eliana ^a   Cutter, Gary R ^c   Mariani, Claudio ^b   Forloni, Gianluigi ^d   Pettenati, Carla ^e   Baron, Pierluigi ^a   Conti, Giancarlo ^a   Bresolin, Nereo ^a   Scarpini, Elio ^a  

^a MAGGIORE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e RHO HOSPITAL   (Italy)

Author keywords

Alzheimer's disease; Chemokines; Genetics; MCP 1; RANTES; Receptors

Indexed keywords

APOLIPOPROTEIN E4; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; ISOLEUCINE; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; VALINE;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CHI-SQUARE DISTRIBUTION; DNA MUTATIONAL ANALYSIS; FEMALE; GENE DELETION; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VALINE;

EID: 4744369272     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2004.07.005     Document Type: Article

References (23)

1. M.Q. Xia, and B.T. Hyman Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease J. Neurovirol. 5 1999 32 41
2. M. Johnstone, A.J.H. Gearing, and K.M. Miller A central role for astrocytes in the inflammatory response to β-amyloid; chemokines, cytokines and reactive oxygen species are produced J. Neuroimmunol. 93 1999 182 193
3. D. Galimberti, N. Schoonenboom, E. Scarpini, P. Scheltens on behalf of the DIAR Group Chemokines in serum and CSF of Alzheimer's disease patients Ann. Neurol. 53 2003 547 548
4. C.C. Broder, and R.G. Collman Chemokine receptors and HIV J. Leukoc. Biol. 62 1997 20 29
5. J.L. He, Y.Z. Chen, M. Farzan, H.Y. Choe, A. Ohagen, and S. Gartner CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia Nature 385 1997 645 649
6. G.J. Nuovo, and M.L. Alfieri AIDS dementia is associated with massive reactive HIV-1 infection and concomitant expression of several cytokines Mol. Med. 2 1996 358 366
7. M.Q. Xia, S.X. Qin, L.J. Wu, C.R. Mackay, and B.T. Hyman Immunohistochemical study of the β-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains Am. J. Pathol. 153 1998 31 37
8. M.W. Smith, M. Dean, M. Carrington, C. Winkler, G.A. Huttley, and D.A. Lomb Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression Science 277 1997 959 965
9. F.S. Wang, W.G. Hong, Y. Cao, M.X. Liu, L. Jin, and L.P. Hu Population survey of CCR5 Δ32, CCR5 m303, CCR2b 64I, and SDF1 3′ A allele frequencies in indigenous Chinese Healthy individuals, and in HIV-1 infected and HIV-1 uninfected individuals in HIV-1 risk groups J. Acquir. Immune Defic. Syndr. 32 2003 124 130
10. R. Mariani, S. Wong, L.C.F. Mulder, D.A. Wilkinson, A.L. Reinhart, and G. LaRosa CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function J. Virol. 73 1999 2450 2459
11. M. Dean, M. Carrington, C. Winkler, G.A. Huttley, M.W. Smith, and R. Allikmets Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort study San Francisco City Cohort, ALIVE Study Science 273 1996 1856 1962
12. O.O. Favorova, T.V. Andreewski, A.N. Boiko, M.A. Sudomoina, A.D. Alekseenkov, and O.G. Kulakova The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4-positive Russians Neurology 59 2002 1652 1655
13. M. Samson, F. Libert, B.J. Doranz, J. Rucker, C. Liesnard, and C.M. Farber Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene Nature 382 1996 668
14. R. Liu, W.A. Paxton, S. Choe, D. Ceradini, S.R. Martin, and R. Horuk Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection Cell 86 1996 367 377
15. A.S. Henderson, S. Easteal, A.F. Jorm, A.J. Mackinnon, A.E. Korten, and H. Christensen Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample Lancet 346 1995 1387 1390
16. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
17. R.C. Petersen, G.E. Smith, S.C. Waring, R.J. Ivnik, E.G. Tangalos, and E. Kokmen Mild cognitive impairment: clinical characterization and outcome Arch. Neurol. 56 1999 303 308
18. N. Hizawa, E. Yamaguchi, K. Furuya, E. Jinushi, A. Ito, and Y. Kawakami The role of the CC chemokine receptor 2 gene polymorphism V64I (CCR2-64I) in sarcoidosis in a Japanese population Am. J. Respir. Crit. Care Med. 159 1999 2021 2023
19. R. Del Bo, G.P. Comi, N. Bresolin, E. Castelli, E. Conti, and A. Degiuli The apolipoprotein E ε4 allele causes a faster decline of cognitive performances in Down's syndrome subjects J. Neurol. Sci. 145 1997 87 91
20. M. Petrek, J. Drabek, V. Kolek, J. Zlamal, K.I. Welsh, and M. Bunce CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis Am. J. Respir. Crit. Care Med. 162 2000 1000 1003
21. R. Miyagishi, M. Niino, T. Fukazawa, I. Yabe, S. Kikuchi, and K. Tashiro C-C chemokine receptor 2 gene polymorphism in Japanese patients with multiple sclerosis J. Neuroimmunol. 145 2003 135 138
22. S.J. Dawson, P.J. Morris, and D.S. Latchman A single amino acid change converts an inhibitory transcription factor into an activator J. Biol. Chem. 271 1996 11631 11633
23. B. Lee, B.J. Doranz, S. Rana, Y. Yi, M. Mellado, and J.M.R. Frade Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4 J. Virol. 72 1998 7450 7458